Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Other Working Capital Changes: 2011-2025

Historic Other Working Capital Changes for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $3.4 million.

  • Mimedx Group's Other Working Capital Changes rose 406.32% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 8643.12%. This contributed to the annual value of $1.1 million for FY2024, which is 172.44% up from last year.
  • Mimedx Group's Other Working Capital Changes amounted to $3.4 million in Q3 2025, which was up 120.23% from $1.6 million recorded in Q2 2025.
  • Mimedx Group's Other Working Capital Changes' 5-year high stood at $3.8 million during Q4 2024, with a 5-year trough of -$6.5 million in Q4 2021.
  • In the last 3 years, Mimedx Group's Other Working Capital Changes had a median value of $699,000 in 2025 and averaged $479,818.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 538.30% in 2023, then surged by 406.32% in 2025.
  • Mimedx Group's Other Working Capital Changes (Quarterly) stood at -$6.5 million in 2021, then surged by 143.97% to $2.8 million in 2022, then declined by 0.42% to $2.8 million in 2023, then surged by 35.49% to $3.8 million in 2024, then skyrocketed by 406.32% to $3.4 million in 2025.
  • Its Other Working Capital Changes stands at $3.4 million for Q3 2025, versus $1.6 million for Q2 2025 and $699,000 for Q1 2025.